EVALUATION OF THE EFFECTIVENESS OF CHEMOTHERAPY OF BREAST CANCER WITH LUNG METASTASES
The article presents the results of estimation of efficiency of chemotherapy in 160 patients with breast cancer (BC) with lung metastases identified within year since the making primary diagnosis. A comparative study of different chemotherapy regimens noted that the AC + AD combination has advantages in achieving objective response and time to progression (P<0,05). Objective response in patients receiving FAS chemotherapy was 52%, while in patients treated with AD regimen - 64%. High efficacy of monotherapy with docetaxel in patients resistant to anthracyclines allows to use this regimen in the second line chemotherapy for the treatment of breast cancer patients with lung metastases.